Clinical study on precise clinical classification and treatment strategy verification of adult onset still's disease

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000036690

Enrollment

Unknown

Registered

2020-08-24

Start date

2021-10-01

Completion date

Unknown

Last updated

2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adult onset still's disease

Interventions

1:MTX

2: Cyclosporin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Meet the Yamaguchi classification standard. 2) Ages 18-75 years, male or female. 3) No hormones, immunosuppressants or biological agents have been used. 4) Women of childbearing age agree to use effective contraception during the study period. 5) Understand the procedure and content of the study, voluntarily sign the informed consent, and accept the requirements of drug use during the study period.

Exclusion criteria

Exclusion criteria: 1) Accompanied by other autoimmune diseases, such as rheumatoid arthritis, Sjogren's syndrome, autoimmune liver disease, hashimoto's thyroiditis. 2) Malignant tumors. 3) Patients with acute infection. 4) Pregnant women or women preparing for pregnancy during the follow-up period. 5) Mental disorders. 6) Participating in other drug trials. 7) Those who are allergic to the drugs in this study.

Design outcomes

Primary

Measure	Time frame
ESR;CRP;ferritin;Body temperature;	—

Secondary

Measure	Time frame
joint tenderness number;joint swelling number;	—

Countries

China

Contacts

Public ContactJialin Teng

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

tengteng8151@sina.com+86 13916224561

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026